Dabigatran Etexilate
Spécifications
211915-06-9Numéro CAS
606-722-8Numéro CE
ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoateNom IUPAC
C34H41N7O5Formule chimique
627.7 g/molMasse molaire
Dabigatran etexilate; Prazaxa; Pradax; BIBR 1048 BS RS1; DTXSID4057681; 2E18WX195X; BIBR1048; DTXCID5031470; Ethyl 3-(((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate; Ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate; ethyl 3-(1-{2-[({4-[amino({[(hexyloxy)carbonyl]imino})methyl]phenyl}amino)methyl]-1-methyl-1H-1,3-benzodiazol-5-yl}-N-(pyridin-2-yl)formamido)propanoate; ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)anilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate; ethyl 3-(1-(2-(((4-(amino((((hexyloxy)carbonyl)imino))methyl)phenyl)amino)methyl)-1-methyl-1H-1,3-benzodiazol-5-yl)-N-(pyridin-2-yl)formamido)propanoate; Etexilate, Dabigatran; RefChem:54924; 211915-06-9; BIBR-1048; BIBR-1048-BS-RS1; CHEBI:70746; 1610666-09-5; MFCD16038312; 1019206-66-6; beta-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester; Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; dabigatran-etexilate; beta-Alanine, N-((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-, ethyl ester; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-ss-Alanine Ethyl Ester; BIBR 1048; Prazaxa; Dabigatran hydrochloride; Dabigatran impurity 92; Dabigatran etexilate [INN]; SCHEMBL505829; SCHEMBL505849; SCHEMBL681224; SCHEMBL944338; UNII-2E18WX195X; GTPL6379; orb1225679; SCHEMBL29354684; SCHEMBL29435446; SCHEMBL31413758; DABIGATRAN ETEXILATE [MI]; Dabigatran etexilate (USAN/INN); GLXC-10464; HMS3744O05; HMS5080G16; DABIGATRAN ETEXILATE [USAN]; BIBR-1048 (Dabigatran etexilate); DABIGATRAN ETEXILATE [VANDF]; Tox21_113924; DABIGATRAN ETEXILATE [MART.]; EBC-11306; EBC-46136; MFCD18385005; DABIGATRAN ETEXILATE [WHO-DD]; PRADAXA (DABIGATRAN ETEXILATE); AKOS015951090; Dabigatran etexilate [USAN:INN:BAN]; CCG-270280; CS-0530; DB06695; FD64991; SB19225; Dabigatran etexilate - Bio-X trade mark; NCGC00262929-01; NCGC00262929-10; AC-22314; BD164344; Ethyl 3-{1-[2-({[4-({[(hexyloxy)carbonyl]amino}methanimidoyl)phenyl]amino}methyl)-1-methyl-1H-1,3-benzodiazol-5-yl]-N-(pyridin-2-yl)formamido}propanoate; HY-10274; SY122248; DB-066446; CAS-211915-06-9; D5904; NS00007001; D07144; EC 606-722-8; EN300-1708005; Z2235811583; Dabigatran Etexilate Mesylate(Discontinued,See C4X-108992); (Z)-Ethyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; .BETA.-ALANINE, N-((2-(((4-((((HEXYLOXY)CARBONYL)AMINO)IMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-, ETHYL ESTER; |_-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester; b-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester; beta-Alanin,N-((2-(((4-((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-ethylester; ethyl (Z)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate; Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate (INN); ethyl 3-[[2-[[4-(N'-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methyl-benzimidazole-5-carbonyl]-(2-pyridyl)amino]propanoate; Ethyl 3-{[(2-{[(4-{[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl)amino}propanoate; Ethyl N-{2-[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}anilino)methyl]-1-methyl-1H-1,3-benzimidazole-5-carbonyl}-N-(pyridin-2-yl)-beta-alaninate; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl] phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester; N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-?-alanine ethyl esterSynonymes
Produits contenant Dabigatran Etexilate
다비란캡슐150mg(다비가트란에텍실레이트)다비란캡슐110mg(다비가트란에텍실레이트)다비올캡슐110밀리그램(다비가트란에텍실레이트)다비올캡슐150밀리그램(다비가트란에텍실레이트)DABIPRAX 75 MG CAPSULAS DURAS EFGDABIPRAX 150 MG CAPSULAS DURAS EFGDABIGATRÁN ETEXILATO STADA 75 MG CAPSULAS DURAS EFGDABIGATRÁN ETEXILATO STADA 150 MG CAPSULAS DURAS EFGDABIGATRÁN ETEXILATO STADA 110 MG CAPSULAS DURAS EFGDABIDOSE 75 MG CAPSULAS DURAS EFGDABIDOSE 150 MG CAPSULAS DURAS EFGDABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG
Page 1 sur 4
Entreprises vendant Dabigatran Etexilate
삼진
삼진제약(주)Republic of KoreaBI
Boehringer Ingelheim International GmbhGermanyTC
Tianjin Chempharmatech.Co.,Ltd.ChinaCA
CHONGQING ASINCAN BIOTECH CO.,LTDChinaEH
Emeishan Hongsen Biopharmaceutical Co., Ltd.ChinaJA
JIANGSU ALPHA PHARMACEUTICAL CO.,LTDChinaCY
Changzhou Yuanda Pharmaceutical Chemical Co.,Ltd.ChinaPage 1 sur 2